https://www.selleckchem.com/pr....oducts/gf109203x.htm
Hepatitis B virus (HBV) vaccination rates are insufficient in high-risk patients worldwide. This study aimed to investigate the screening, immunization, and vaccination rates in three high-risk groups for HBV infection allogeneic hematopoietic stem cell transplantation (AHSCT), renal transplantation (RT), and chronic hepatitis C (CHC) groups. The serological data of consecutive patients between 2014 and 2019 were reviewed using the hospital database. The HBV screening rates were 100.0%, 90.4%, and 82.4% in the AHSCT, CHC, and RT group
Like
Comment
Share
